Join the Major Depressive Disorder group to help and get support from people like you.
Major Depressive Disorder News (Page 21)
Related terms: Clinical Depression, Unipolar Disorder, MDD
Cognitive Behavioral Therapy Aids Outcomes One Year After Bariatric Surgery
FRIDAY, Aug. 4, 2023 – Telephone-based cognitive behavioral therapy (tele-CBT) delivered one year after bariatric surgery is associated with improvements in disordered eating and psychological...
Troubled Childhood Could Mean a Troubled Old Age, Study Finds
FRIDAY, Aug. 4, 2023 – The trauma and unhappy family dynamics of childhood may follow kids into old age, affecting both their mind and body, according to new research. “We looked at self-reported d...
Think Your Job Is 'Socially Useless'? You're Not Alone
FRIDAY, Aug. 4, 2023 – Ever feel like your job is pointless? A big part of the population feels just that way — that the jobs they do matter little to society. And a Swiss study that delved into w...
People With Mental Disorders Less Likely to Complete CRC Screening
THURSDAY, Aug. 3, 2023 – People with mental disorders are less likely to participate in colorectal cancer screening versus those without these disorders, according to a study published in the July...
Zuranolone Pill to Counter Postpartum Depression Looks Good in Trial and May Gain FDA Approval
WEDNESDAY, Aug. 2, 2023 – All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may quickly treat and ease severe postpartum depression....
Prevalence of Neuropsychiatric Symptoms Up for Autoimmune Rheumatic Disease
TUESDAY, Aug. 1, 2023 – The prevalence of all self-reported neuropsychiatric symptoms is significantly higher in those with systemic autoimmune rheumatic diseases (SARDs) versus controls, according...
Summer Jobs Give Kids More Than a Paycheck
SATURDAY, July 29, 2023 – Summer jobs can give teens valuable life experience that help them transition to adulthood – not just a paycheck, according to the American Academy of Pediatrics. Benefits...
Your Teen & Social Media: Experts Offer Tips to Parents
MONDAY, July 31, 2023 – When parents meet U.S. Surgeon General Dr. Vivek Murthy, one concern comes up time after time. "The most common question parents ask me is: 'Is social media safe for my...
With New Proposed Rules, Biden Administration Pushes Insurers to Boost Mental Health Coverage
WEDNESDAY, July 26, 2023 – President Joe Biden announced Tuesday that his administration is seeking new rules to push insurance companies to increase coverage of mental health treatment. The new...
Over Half of People With Autoimmune Conditions Suffer Depression, Anxiety
WEDNESDAY, July 26, 2023 – More than half of all patients with autoimmune diseases also suffer from depression and anxiety – but most are never asked about their mental health, a new study finds....
With New Proposed Rules, Biden Administration Pushes Insurers to Boost Mental Health Coverage
WEDNESDAY, July 26, 2023 – President Joe Biden announced Tuesday that his administration is seeking new rules to push insurance companies to increase coverage of mental health treatment. The new...
Risk for Incident Dementia Increased With Diagnosed Depression
MONDAY, July 24, 2023 – Men and women with diagnosed depression have an increased risk for dementia, according to a study published online July 24 in JAMA Neurology. Holly Elser, M.D., Ph.D., from...
U.S. FDA Approves Vraylar (cariprazine) as an Adjunctive Treatment for Major Depressive Disorder
Approval marks fourth indication for Vraylar, backed by proven efficacy and well-established tolerability as an adjunctive treatment for major depressive disorder (MDD) with an antidepressant...
FDA Approves Auvelity (dextromethorphan and bupropion) for the Treatment of Major Depressive Disorder in Adults
Auvelity is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to placebo starting at one week11-4...
FDA Approves Spravato (esketamine) Nasal Spray for Treatment-Resistant Depression
March 5, 2019 – The U.S. Food and Drug Administration today approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults who have...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Related drug support groups
Lexapro, Zoloft, sertraline, Wellbutrin, Cymbalta, trazodone, Prozac, Effexor, escitalopram, view more... bupropion, mirtazapine, Abilify, venlafaxine, fluoxetine, Paxil, Effexor XR, Pristiq, Wellbutrin XL, Viibryd, duloxetine, Trintellix, quetiapine, Remeron, Wellbutrin SR, Vraylar, paroxetine, olanzapine, Zyprexa, vortioxetine, aripiprazole, Rexulti, Seroquel XR, doxepin, Auvelity, desvenlafaxine